OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Switching from intravenous to subcutaneous infliximab and vedolizumab in patients with inflammatory bowel disease: impact on trough levels, day hospital visits, and medical expenses
Jenniina Harno-Tasihin, Laura Siregar, Mikko Paajanen, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 3, pp. 280-287
Closed Access | Times Cited: 4
Jenniina Harno-Tasihin, Laura Siregar, Mikko Paajanen, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 3, pp. 280-287
Closed Access | Times Cited: 4
Showing 4 citing articles:
Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease
Jaakko Rautakorpi, Sara Kolehmainen, Eliisa Löyttyniemi, et al.
Digestive Diseases and Sciences (2025)
Open Access
Jaakko Rautakorpi, Sara Kolehmainen, Eliisa Löyttyniemi, et al.
Digestive Diseases and Sciences (2025)
Open Access
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study
Ferdinando D’Amico, Luca Massimino, Giulia Palmieri, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 2
Ferdinando D’Amico, Luca Massimino, Giulia Palmieri, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 2
Switching from Intravenous to Subcutaneous Biological Therapy for Inflammatory Bowel Disease Patients Remains a Challenge
Vered Richter, Daniel L. Cohen, Ofra Kriger-Sharabi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1357-1357
Open Access | Times Cited: 1
Vered Richter, Daniel L. Cohen, Ofra Kriger-Sharabi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1357-1357
Open Access | Times Cited: 1
Subcutaneous versus intravenous infliximab therapy – a real-world study: toward higher drug concentrations
Ana Isabel Ferreira, Tiago Lima Capela, Cátia Arieira, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 11, pp. 1314-1318
Closed Access
Ana Isabel Ferreira, Tiago Lima Capela, Cátia Arieira, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 11, pp. 1314-1318
Closed Access
